Results 1 to 10 of about 32,244 (180)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine a Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates [PDF]

open access: yesCase Reports in Ophthalmology, 2016
Subepithelial infiltrates secondary to adenoviral keratoconjunctivitis may persist for years and cause blurred vision, halos, glare, and photophobia. These infiltrates arise from immune reaction against the virus, and few studies have reported topical ...
Ömür Uçakhan Gündüz
exaly   +5 more sources

Evaluating the Efficacy of Topical Tacrolimus Alone and in Combination With Prednisolone for Treating Subepithelial Infiltrates in Epidemic Keratoconjunctivitis [PDF]

open access: yesBiomedicines
Purpose: Epidemic keratoconjunctivitis (EKC) is a common viral ocular infection that can lead to persistent subepithelial infiltrates (SEIs), resulting in significant visual impairment and patient discomfort, necessitating effective treatment strategies ...
Emine Esra Karaca, Özlem Evren Kemer
exaly   +5 more sources

Comparison of the safety and efficacy of topical Tacrolimus (0.03%) versus dexamethasone (0.05%) for subepithelial infiltrates after adenoviral conjunctivitis [PDF]

open access: yesIndian Journal of Ophthalmology, 2019
Purpose: To compare the safety and efficacy of tacrolimus 0.03% ointment with dexamethasone 0.05% ointment for subepithelial infiltrates (SEIs) following adenoviral keratoconjunctivitis (AK).
Rahul Bhargava, Prachi Kumar
doaj   +3 more sources

The efficacy of combined povidone-iodine 1% and dexamethasone 0.08% prepared eye drops in treating post-viral corneal subepithelial infiltrates [PDF]

open access: yesIndian Journal of Ophthalmology
Purpose: To evaluate the efficacy of povidone-iodine 1.0% and dexamethasone 0.08% combination eye drops in treating post-viral corneal subepithelial infiltrates (SEIs).
Mowaffaq K Alkassasbeh   +6 more
doaj   +3 more sources

Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis [PDF]

open access: yesInternational Journal of Ophthalmology, 2016
Letter to the ...
Ilkay Kilic Muftuoglu   +2 more
doaj   +2 more sources

Evaluating anterior corneal surface using Placido ring mires for irregular astigmatism in refractory corneal subepithelial infiltrates after adenoviral conjunctivitis [PDF]

open access: yesBMC Ophthalmology
Background Corneal subepithelial infiltrates (SEIs) are characteristic clinical findings of adenoviral keratoconjunctivitis (AKC). In eyes with SEIs, both corneal opacity and irregular astigmatism may interfere with vision. However, irregular astigmatism
Noriko Toyokawa   +3 more
doaj   +2 more sources

Evaluation of the effect of subepithelial infiltrates following adenoviral keratoconjunctivitis on corneal biomechanics: Corvis ST analysis [PDF]

open access: yesBMC Ophthalmology
Background The purpose of this study was to evaluate the impact of subepithelial infiltrates (SEIs) developing after adenovirus epidemic keratoconjunctivitis (EKC) on corneal densitometry and biomechanical properties.
Hafize Gökben Ulutaş   +3 more
doaj   +2 more sources

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis [PDF]

open access: yesBMC Ophthalmology, 2012
Background To evaluate the treatment with topical 0.05% cyclosporine A (CsA) in patients with subepithelial corneal infiltrates (SEI). Methods We reviewed 16 patients (22 eyes) before and after the treatment with 0.05% CsA eye drops.
Okumus Seydi   +7 more
doaj   +2 more sources

An Update on Viral Conjunctivitis Treatment Strategies: A Narrative Literature Review [PDF]

open access: yesMicroorganisms
Viral conjunctivitis is a highly contagious ocular condition that significantly impacts patient quality of life and healthcare resources. Despite its self-limiting nature, the condition remains a significant public health concern due to its high ...
Maheshver Shunmugam   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy